In line with previous results25,43,145, we here demonstrate that PCNSL are defined by recurrent and often biallelic CDKN2A deletions, MYD88 L265P mutations, and mutations that activate BCR signaling, genetic hallmarks of the DLBCL subtype MCD/C530,31. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.